Actor Portrayal
WEBINAR LIBRARY
Peer Insights On Demand
An exploration of the evolution of testosterone therapy and the growing role of oral options. Reviews Phase III clinical data on KYZATREX, treatment considerations, and practical guidance for managing patient expectations when initiating oral TRT.
Watch Now
Educational Insights on KYZATREX®
Dr. Andrew Sun addresses key questions about KYZATREX in these educational videos, including testosterone level changes, liver safety, and best practices for monitoring patient labs.
What are the Expected Changes in Free Testosterone and SHBG With KYZATREX?
What is the Risk of Liver Toxicity With KYZATREX?
What is the Optimal Lab Timing for Patients Taking KYZATREX?
What is the Optimal Time of Day to Test Testosterone Levels to Ensure Accurate Results
PUBLISHED PHASE III DATA
Peer-Reviewed, Open-Access, Published in 2024
Bernstein JS, Dhingra OP. A phase III, single-arm, 6-month trial of a wide-dose range oral testosterone undecanoate product. Ther Adv Urol. 2024;16:17562872241241864. doi:10.1177/17562872241241864
Access Open-Access DOI
Clinical Resources for Download
HCP Brochure
Comprehensive overview of indication, efficacy data, safety profile, dosing, and patient type considerations.
Full Prescribing Information
Complete PI, contraindications, warnings, drug interactions, and dosing guidance.
Medication Guide
FDA-required patient-facing medication guide — required to be dispensed with each KYZATREX prescription.
Actor Portrayals